15 / 18
Page 47
conferenceseries
.com
Volume 8
Journal of Clinical & Experimental Pharmacology
Pharmacology and Medicinal Chemistry 2018
October 18-19, 2018
October 18-19, 2018 Dubai, UAE
International Conference on
18
th
International Conference on
&
Joint Meeting on
Pharmacology and Toxicology
Medicinal and Pharmaceutical Chemistry
Social pharmacy as a social aspect of Pharmaco-epidemiology: Now more than ever
Payam Peymani
Shiraz University of Medical Sciences, Iran
S
ince pharmacy is increasingly assuming the role of ‘primary and secondary health care professionals’, rather than being
solely dispensers of medicines and suppliers of medical appliances, pharmacy students and researchers require new
proficiencies as communicators, problem-solvers and advisers. ‘Social, behavioral and cognitive science’ has been identified
as having a significant contribution to make in the educational training of pharmacists. In this lecture we are concerned
specifically with the application of sociology to the practice of pharmacy. Social pharmacy is a file riven by social demands.
By studying the relationship between pharmaceutical sciences, society and humanistic perspectives, particularly through case
studies, the impact of medication and changes in societal expectation of them, as well as through historical background studies
and surveys of current movement, this field acts to determine the roles of pharmacists and pharmacies expected by society.
Social pharmacy requires a basic knowledge of pharmaceutical science, but an understanding from socio-economic viewpoints
of the current status and structures in which healthcare functions is important as well. So far, social pharmacy has played a vital
and necessary role in training curriculum for community-based pharmacists. Social pharmacy may be seen as including of
all social indicators influencing the use of a particular drug, like drug-related beliefs, regulations, policy, knowledge, attitudes,
practice, medicine information, ethics and behavior. Social pharmacy programs in pharmacy curricula are becoming more
crucial and essential because of the various factors that can affect the health of a society. Social pharmacy deals with the study
of community and human act and as a behavioral science is often related with disciplines that deal with individuals as well
as large and small groups, including psychology, sociology and anthropology. So it can be discussed that social pharmacy
begins with a rationale of social, cognitive and behavioral sciences to educational course for pharmacists and its inclusion
in the curriculum and also establish of departments, centers and journals of social pharmacy, which is a prerequisite for the
development of the concept of social pharmacy and its further implementation in real world evidence and practice.
Biography
Payam Peymani is currently an Assistant Professor and Director of Pharmacoepidemiology and Pharmacoeconomics Group, Health Policy Research Center of
Shiraz University of Medical Sciences. Also, He is a Director of Accreditation and Ranking Directorate, Vice Chancellery for Global Strategies and International
Affairs, Shiraz University of Medical Sciences Shiraz, Iran. He is the author of more than 40 peer review papers, and participated and gave presentation in more
than 34 international Congress and symposia and has been a reviewers of various international scientific journals. He is a Member of Pharmacoepidemiology
Committee of Shiraz University of sciences. He is an Editorial Manager and Associated Editor of the Social Pharmacy Journal. Dr. Peymani has a more than 6
years' experience of designing and conducting clinical trials, Pharmacoepidemiology , population Based and social pharmacy Study. Dr Peymani obtained his
MPhil of Health Policy and PhD of Clinical Pharmacology (Pharmacoepidemiology) from Health Policy Research Center, Shiraz University of Medical Sciences in
2013 and 2016 respectively. He received his Pharmacy Doctorate (Pharm.D) degree in Pharmaceutical Sciences from Faculty of Pharmacy, Shiraz University of
Medical Sciences in 2010.Currently, His is involved in Pharmacoepidemiology, Pharmacovigilance and population Based study and his main research interest is in
the design and conduct Clinical Trial and Pharmacoepidemiology / drug safety evaluation.
peymani.payam@gmail.comPayam Peymani, Clin Exp Pharmacol 2018, Volume 8
DOI: 10.4172/2161-1459-C3-034